FLT3 antibody-based therapeutics for leukemia therapy.

Abstract:

:Antibodies represent a unique class of therapeutics because of their high specificity toward a defined target antigen. Recent clinical success with antibody-based cancer therapeutics has led to an upsurge in the development of these agents. Antibodies directed against FLT3 represent a promising approach for the treatment of human leukemia. We discuss some basic aspects of antibody-based cancer therapeutics, including their mechanisms of action, with a focus on recent progress in the generation and development of anti-FLT3 antibodies as well as their therapeutic potentials in the treatment of human hematologic malignancies.

journal_name

Int J Hematol

authors

Li Y,Zhu Z

doi

10.1532/IJH97.05068

subject

Has Abstract

pub_date

2005-08-01 00:00:00

pages

108-14

issue

2

eissn

0925-5710

issn

1865-3774

pii

4EA26P5164G8RCD4

journal_volume

82

pub_type

杂志文章,评审
  • Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.

    abstract::According to the 2008 WHO classification, the category of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) includes atypical chronic myeloid leukaemia (aCML), chronic myelomonocytic leukaemia (CMML), MDS/MPN-unclassifiable (MDS/MPN-U), juvenile myelomonocytic leukaemia (JMML) and a "provisional" entity, refracto...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-014-1670-3

    authors: Zoi K,Cross NC

    更新日期:2015-03-01 00:00:00

  • Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase

    abstract::Rapid vitamin K antagonist (VKA) reversal is required in patients experiencing major bleeding or requiring urgent surgery. Four-factor prothrombin complex concentrate (4F-PCC; Beriplex®/Kcentra®) was shown in two large randomized controlled, international phase 3b trials to be an effective alternative to plasma for ur...

    journal_title:International journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s12185-017-2311-4

    authors: Kushimoto S,Fukuoka T,Kimura A,Toyoda K,Brainsky A,Harman A,Chung T,Yasaka M

    更新日期:2017-12-01 00:00:00

  • Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.

    abstract::Increased levels of asparagine synthetase (ASNS), an enzyme producing intracellular asparagine, have been implicated in the development of asparaginase resistance. The aim of this study was to assess ASNS mRNA and protein expression in bone marrow cell populations of children with acute lymphoblastic leukemia (ALL). B...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-014-1509-y

    authors: Dimitriou H,Choulaki C,Perdikogianni C,Stiakaki E,Kalmanti M

    更新日期:2014-03-01 00:00:00

  • Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma.

    abstract::We present a patient with refractory multiple myeloma who showed a good response to a combination therapy with oral melphalan, dexamethasone, and thalidomide (MDT). A 48-year-old woman with myeloma refractory to thalidomide, dexamethasone, and clarithromycin received 6 mg melphalan for 4 days every 6 weeks in combinat...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1532/IJH97.06164

    authors: Asou N,Izuno Y,Okubo T,Ide K,Ueno H,Kawakita M,Mitsuya H,Hata H

    更新日期:2007-07-01 00:00:00

  • Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia.

    abstract::The introduction of all-trans retinoic acid (ATRA) has made acute promyelocytic leukemia (APL) a curable disease; however, early death prior to the completion of treatment remains a problem. In quantitative evaluation of response to ATRA treatment, lymphocytes must be excluded as they do not originally have t(15;17). ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-018-2472-9

    authors: Sato K,Sakai H,Saiki Y,Uchida A,Uemura Y,Yokoi S,Tsuruoka Y,Nishio Y,Matsunawa M,Suzuki Y,Isobe Y,Kato M,Tomita N,Inoue Y,Miura I

    更新日期:2018-09-01 00:00:00

  • Highly conserved antigenic structure of the factor VIII C2 domain in some mammals.

    abstract::To elucidate differences in the antigenic structure of factor VIII (FVIII) among mammals, we evaluated cross-reactivities of well-defined antihuman FVIII antibodies with canine and other mammalian FVIII proteins. Monoclonal antibodies against human FVIII recognizing the A1 domain in the heavy chain and the A3 domain i...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1532/IJH97.05081

    authors: Ori J,Tanaka I,Kubota Y,Shima M,Matsumoto T,Yoshida K,Sakurai Y,Yoshioka A

    更新日期:2005-11-01 00:00:00

  • Successful mobilization of peripheral blood stem cells with bortezomib + high-dose cyclophosphamide + G-CSF in a light chain myeloma patient after failure with Total Therapy 2.

    abstract::Autologous stem cell transplantation is considered the best post-induction therapy for multiple myeloma (MM). Therefore, therapy for myeloma should be chosen not only on the basis of efficacy, but also taking into account their impact on the hematopoietic stem cell compartment. We describe the case of a MM patient in ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-009-0354-x

    authors: Giglio G,Romito S,Carrozza F,Musacchio M,Antuzzi G,Gigli R,Magri M,Bavaro P,Di Bartolomeo P,Dell'Isola M,Accorsi P

    更新日期:2009-07-01 00:00:00

  • Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone.

    abstract::A 68-year-old female was diagnosed with acute myeloid leukemia (AML-M2 without 8/21 translocation) in December 2006. Although a complete remission (CR) was obtained after induction chemotherapy, the first post-remission therapy was discontinued because of severe cardiovascular complications. She had a relapse of AML w...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1481-y

    authors: Tsunemine H,Akasaka H,Sakane EI,Ito K,Kodaka T,Takahashi T

    更新日期:2014-02-01 00:00:00

  • Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.

    abstract::Internal tandem duplication in the FLT3 gene (FLT3/ITD), which is found in patients with acute myeloid leukemia (AML), causes resistance to FLT3 inhibitors. We found that RUNX1, a transcription factor that regulates normal hematopoiesis, is up-regulated in patients with FLT3/ITD(+) AML. While RUNX1 can function as a t...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-015-1908-8

    authors: Hirade T,Abe M,Onishi C,Taketani T,Yamaguchi S,Fukuda S

    更新日期:2016-01-01 00:00:00

  • Pediatric post-transplant diffuse large B cell lymphoma after cardiac transplantation.

    abstract::Post-transplant lymphoproliferative disorders (PTLDs) occur in 3.5-9% of patients after pediatric cardiac transplantation. Caution is needed when treating patients with PTLD because of the risk of allograft rejection frequently caused by withdrawal of immunosuppression. In this report, we describe a 47-month-old boy w...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-008-0250-9

    authors: Kusuki S,Hashii Y,Fukushima N,Takizawa S,Tokimasa S,Kogaki S,Ohta H,Tsuda E,Nakagawa A,Ozono K

    更新日期:2009-03-01 00:00:00

  • Application of natural killer T-cells to posttransplantation immunotherapy.

    abstract::Graft-versus-host disease (GVHD) and graft-versus leukemia (GVL) effects are closely related to each other after allogeneic stem cell transplantation. This association exists because of the extensive and complicated interaction between cellular donor components and recipient components concomitant with cytokine storms...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/BF02983991

    authors: Fujii S

    更新日期:2005-01-01 00:00:00

  • Multiple myeloma presenting as bilateral breast lumps in pregnant woman.

    abstract:BACKGROUND:Multiple myeloma (MM) is a systemic disease in the elderly. Its incidence in patients younger than 40 years old and especially in pregnant women is extremely rare. MM may involve extraosseous sites, and only in rare cases it is observed in the breast. CASE REPORT:We describe the case of a 39-year-old woman ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1420-y

    authors: Bouzguenda R,Khanfir A,Toumi N,Chaaben K,Hentati Y,Ayadi L,Feki W,Daoud J,Frikha M

    更新日期:2013-10-01 00:00:00

  • Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?

    abstract::The life expectancy of thalassemic patients has increased, and now approaches that of healthy individuals, thanks to improved treatment regimens. However, pregnancy in women with β-Thalassemia Μajor remains a challenging condition. Recent advances in managing this haemoglobinopathy offer the potential for safe pregnan...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-016-1945-y

    authors: Diamantidis MD,Neokleous N,Agapidou A,Vetsiou E,Manafas A,Fotiou P,Vlachaki E

    更新日期:2016-05-01 00:00:00

  • Prognostic value of early response to treatment combined with conventional risk factors in pediatric acute lymphoblastic leukemia.

    abstract::To determine useful prognostic factors in treating childhood acute lymphoblastic leukemia (ALL), we correlated conventional risk factors and bone marrow response 14 days after induction chemotherapy. Our study included 116 precursor B-cell (n = 104) and T-cell (n = 12) ALL patients treated with our protocol between 19...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1532/ijh97.04114

    authors: Morimoto A,Kuriyama K,Hibi S,Todo S,Yoshihara T,Kuroda H,Imashuku S

    更新日期:2005-04-01 00:00:00

  • Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study.

    abstract::This study aimed at assessing the relationship between thrombosis, hyperhomocysteinemia and vitamin B12 deficiency using a case-control study carried out in 326 patients with thrombosis (case group) and 351 patients from the same hospital (control group). Apart from the classic risk factors, a number of hematological ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-011-0825-8

    authors: Remacha AF,Souto JC,Piñana JL,Sardà MP,Queraltó JM,Martí-Fabregas J,García-Moll X,Férnandez C,Rodriguez A,Cuesta J

    更新日期:2011-04-01 00:00:00

  • Two case reports of inherited antithrombin deficiency: a novel frameshift mutation and a large deletion including all seven exons detected using two methods.

    abstract::An inherited antithrombin deficiency is an autosomal dominant thrombotic disorder. We identified two pedigrees of inherited type I antithrombin deficiency and two responsible mutations in each. A novel 21-22delAA appeared to have caused a frameshift with a premature termination at amino acid +63 in one patient and a l...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-010-0763-x

    authors: Sekiya A,Morishita E,Karato M,Maruyama K,Shimogawara I,Omote M,Wakugawa Y,Shinohara M,Hayashi T,Kadohira Y,Asakura H,Nakao S,Ohtake S

    更新日期:2011-02-01 00:00:00

  • CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement.

    abstract::A 67-year-old man suffered from a left cervical lymph node swelling and tenderness. Biopsy of the cervical lymph node showed pleomorphic large cells containing large atypical nuclei. Immunohistochemical stains of these cells were positive for CD30, but negative for CD3 and CD20. After the biopsy, his left cervical ski...

    journal_title:International journal of hematology

    pub_type: 信件

    doi:10.1007/s12185-010-0675-9

    authors: Asano H,Imai Y,Ota S,Yamamoto G,Takahashi T,Fukayama M,Kurokawa M

    更新日期:2010-10-01 00:00:00

  • Clinicopathological characteristics of erythroblast-rich RAEB and AML M6a in children.

    abstract::The distinction between RAEB, RAEB-T and AML M6a is difficult when erythroblasts in the bone marrow (BM) exceed 50%. We analyzed 19 children (2 RAEB, 13 RAEB-T and 4 AML M6a) enrolled in a prospective pathological central review in Japan and divided them into two groups according to the myeloblasts percentage among no...

    journal_title:International journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s12185-008-0183-3

    authors: Honda Y,Manabe A,Tsuchida M,Zaike Y,Masunaga A,Inoue M,Kobayashi R,Ohtsuka Y,Kikuchi A,Nakahata T,From the MDS Committee, the Japanese Society of Pediatric Hematology.

    更新日期:2008-12-01 00:00:00

  • Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.

    abstract::Osteonecrosis (ON) is a potentially disabling complication encountered in children who receive chemotherapy for acute lymphoblastic leukemia (ALL). Considering the possible effect of ethnic difference on the clinical features of symptomatic ON in pediatric ALL, we retrospectively evaluated 245 children with ALL who we...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-015-1790-4

    authors: Chen SH,Chang TY,Jaing TH,Lee MS,Wang CJ,Hung IJ,Yang CP

    更新日期:2015-07-01 00:00:00

  • Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.

    abstract::In addition to reduced-intensity conditioning, which has expanded the eligibility for hematopoietic cell transplantation (HCT) to older patients, increased availability of alternative donors, including HLA-mismatched unrelated donors, has increased access to allogeneic HCT for more patients. However, acute graft-versu...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-013-1421-x

    authors: Maeda Y

    更新日期:2013-09-01 00:00:00

  • Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis.

    abstract::We performed autologous CD34+ stem cell transplantation in 3 patients with juvenile rheumatoid arthritis (JRA) refractory to conventional treatment. All patients had systemic type JRA. In case 1 (a 3-year-old boy), purified CD34+ cells from bone marrow were transplanted after a preconditioning regimen consisting of cy...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02983820

    authors: Kishimoto T,Hamazaki T,Yasui M,Sasabe M,Okamura T,Sakata N,Inoue M,Yagi K,Kawa K

    更新日期:2003-12-01 00:00:00

  • EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus.

    abstract::Primary effusion lymphoma (PEL) is a rare type of extranodal lymphoma, typically of a B-cell origin, which presents as lymphomatous effusion with no nodal enlargement or tumor masses. The development PEL is universally associated with human herpes virus-8 (HHV-8) infection. Cases of HHV-8-negative primary lymphomatous...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-018-2426-2

    authors: Okada K,Asakura S,Yano T,Kishimoto T

    更新日期:2018-09-01 00:00:00

  • Serum stem cell factor levels in patients with aplastic anemia.

    abstract::Immune suppression of hematopoiesis has been implicated in the pathogenesis of acquired aplastic anemia. Similarly, abnormalities of T cells and bone marrow stromal cells have been reported in aplastic anemia, as has abnormal cytokine production. Stem cell factor (SCF) (also known as kit ligand, mast cell growth facto...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Nimer SD,Leung DH,Wolin MJ,Golde DW

    更新日期:1994-10-01 00:00:00

  • Low expression of FCGRIIB in macrophages of immune thrombocytopenia-affected individuals.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune disorder described as autoantibody-mediated platelet deterioration. Platelets with affiliated IgG are targeted for exploitation by Fc receptor-mediated phagocytic cellular material within the reticuloendothelial system. The objective of this research is to investigate the...

    journal_title:International journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s12185-012-1187-6

    authors: Wu Z,Zhou J,Prsoon P,Wei X,Liu X,Peng B

    更新日期:2012-11-01 00:00:00

  • A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia.

    abstract::Acute promyelocytic leukemia (APL) is characterized by t(15;17)(q22;q21), which results in the fusion of the promyelocytic leukemia (PML) gene at 15q22 with the retinoic acid alpha-receptor (RARA) at 17q21. We report a patient with APL carrying a new complex variant translocation (5;17;15;20). Spectral karyotyping ana...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-011-0929-1

    authors: Yamanouchi J,Hato T,Niiya T,Miyoshi K,Azuma T,Sakai I,Yasukawa M

    更新日期:2011-10-01 00:00:00

  • In vitro cleavage of the MLL gene by topoisomerase II inhibitor (etoposide) in normal cord and peripheral blood mononuclear cells.

    abstract::The correlation between infant leukemia and in utero exposure to topoisomerase II (topo-II) inhibitor has been clarified. We examined the in vitro effect of topo-II inhibitor (etoposide) on cleavage of the MLL gene in cord and peripheral blood mononuclear cells (MNCs). Southern blot analysis showed cleavage of the MLL...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02982722

    authors: Ishii E,Eguchi M,Eguchi-Ishimae M,Yoshida N,Oda M,Zaitsu M,Fujita I,Miyazaki S,Hamasaki Y,Mizutani S

    更新日期:2002-07-01 00:00:00

  • Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.

    abstract::We have previously shown the clinical usefulness of Wilms' tumor 1 gene (WT1) mRNA expression in peripheral blood (PB) as a minimal residual disease (MRD) monitoring marker in 191 acute myeloid leukemia (AML) patients using the WT1 mRNA assay kit "Otsuka" (Otsuka Pharmaceutical Co., Ltd.; "former kit"). In contrast, t...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-015-1882-1

    authors: Kitamura K,Nishiyama T,Ishiyama K,Miyawaki S,Miyazaki K,Suzuki K,Masaie H,Okada M,Ogawa H,Imai K,Kiyoi H,Naoe T,Yokoyama Y,Chiba S,Hata T,Miyazaki Y,Hatta Y,Takeuchi J,Nannya Y,Kurokawa M,Ueda Y,Koga D,Sugiyam

    更新日期:2016-01-01 00:00:00

  • Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

    abstract::Narrowband ultraviolet B phototherapy (NB-UVB) is a therapeutic alternative for haematopoietic stem cell transplantation-related skin graft-versus-host disease (GVHD). The beneficial effects of this intervention may be induced by direct irradiation of inflammatory cells in the skin; however, the putative involvement o...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-014-1530-1

    authors: Iyama S,Murase K,Sato T,Hashimoto A,Tatekoshi A,Horiguchi H,Kamihara Y,Ono K,Kikuchi S,Takada K,Kawano Y,Hayashi T,Miyanishi K,Sato Y,Takimoto R,Kobune M,Mori S,Kato J,Yamashita T,Kato J

    更新日期:2014-04-01 00:00:00

  • Recombinant factor VIIa: a review on its clinical use.

    abstract::Recombinant activated factor VII (rFVIIa) (NovoSeven) is a novel hemostatic agent originally developed to treat bleeding episodes in hemophilic patients with inhibitors against coagulation factors VIII and IX. In recent years, rFVIIa has also been employed for the management of uncontrolled bleeding in a number of con...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1532/IJH97.E0517

    authors: Franchini M

    更新日期:2006-02-01 00:00:00

  • Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone.

    abstract::Vincristine-adriamycin-dexamethasone (VAD) regimen with intermittent high-dose dexamethasone (HD) has been used as primary chemotherapy for multiple myeloma (MM) patients who are candidates for high-dose therapy or present with renal failure. However, dexamethasone increases the risk of infection in MM patients. We re...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-010-0735-1

    authors: Isoda A,Matsumoto M,Nakahashi H,Mawatari M,Manaka A,Sawamura M

    更新日期:2011-01-01 00:00:00